Inspira™ Technologies Collaborates With Zriha Medical To Launch Cutting-Edge Production Line

Company Collaboration and Production - Inspira Technologies is establishing a dedicated production line for a crucial component of its respiratory support system in collaboration with Zriha Medical Ltd, a leading international manufacturer specializing in medical device production [1] - The collaboration involves the manufacture of a flow mechanism integrated into Inspira's products for use in extracorporeal circulation of blood during oxygenation [1] - Zriha Medical's capabilities in precision assembly and clean room environments are well-suited for this collaboration, potentially enabling Inspira to scale up production and accelerate market entry [2] - Zriha Medical brings over 50 years of experience in advanced plastic and silicone injection, metal processing technologies, and ISO 13485-certified clean room facilities [2] Inspira Technologies' Products and Market - Inspira Technologies is an innovative medical technology company focused on life support and respiratory treatment, with a breakthrough Augmented Respiration Technology (INSPIRA™ ART) targeting the $19 billion mechanical ventilation market [3] - The INSPIRA ART offers a potential alternative to mechanical ventilators by stabilizing oxygen saturation levels in minutes without requiring patients to be sedated, with 20 million ICU patients suffering from acute respiratory failure annually [3] - The INSPIRA ART is equipped with a clip-on HYLA™ blood sensor, a real-time continuous blood monitoring technology designed to alert physicians of changes in patient conditions without intermittent blood sampling [3] - The INSPIRA™ ART100 system has obtained FDA 510(k) clearance for use in CBP procedures and Israeli AMAR certification for ECMO and Cardiopulmonary Bypass procedures [4] Product Development and Regulatory Status - Inspira's other products, including the INSPIRA™ ART500 (Gen 2), INSPIRA™ Cardi-ART portable modular device, VORTX™ Oxygen Delivery System, and HYLA™ blood sensor, are currently in the design and development phase and have not yet been tested in humans or approved by regulatory entities [5]